Feb 13, 2017 21:30 pm UTC| Business
NASHVILLE, Tenn. GREENWOOD VILLAGE, Colo., Feb. 13, 2017 -- Envision Healthcare Corporation (NYSE: EVHC) today announced it will release its fourth-quarter and full-year 2016 financial results on Tuesday, February 28,...
Intuitive Surgical Reports New Employee Option Grants for February 2017
Feb 13, 2017 21:30 pm UTC| Business
SUNNYVALE, Calif., Feb. 13, 2017 -- Intuitive Surgical, Inc. (Nasdaq:ISRG) today reported that equity awards, approved by the Compensation Committee of the Board of Directors, which consists entirely of Independent...
Retrophin Appoints William Rote Senior Vice President, Research and Development
Feb 13, 2017 21:30 pm UTC| Business
SAN DIEGO, Feb. 13, 2017 -- Retrophin, Inc.(NASDAQ:RTRX) today announced William “Bill” Rote, Ph.D. has been appointed senior vice president, research and development, effective immediately. Dr. Rote will oversee all...
Crown Castle Raises Additional Term Loans and Extends Maturity of Existing Facilities
Feb 13, 2017 21:19 pm UTC| Business
HOUSTON, Feb. 13, 2017 -- Crown Castle International Corp. (NYSE:CCI) (“Crown Castle”) today announced that it borrowed $500 million of additional Tranche A Term Loans (“Additional Term Loans”) and extended the maturity...
Diversicare to Announce Fourth Quarter 2016 Financial Results on Thursday, March 2, 2017
Feb 13, 2017 21:16 pm UTC| Business
BRENTWOOD, Tenn., Feb. 13, 2017 -- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR) today announced that it is scheduled to report financial results for its fourth quarter ended December 31, 2016, on Thursday, March...
Diversicare to Announce Fourth Quarter 2016 Financial Results on Thursday, March 2, 2017
Feb 13, 2017 21:16 pm UTC| Business
BRENTWOOD, Tenn., Feb. 13, 2017 -- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR) today announced that it is scheduled to report financial results for its fourth quarter ended December 31, 2016, on Thursday, March...
Feb 13, 2017 21:16 pm UTC| Business
Merger creates a clinical-stage biopharmaceutical company focused on the discovery and development of select microRNA-targeted therapies Combined company, renamed Miragen Therapeutics, Inc., to commence trading on Nasdaq...